Price to Book Value Chart

Historical Price to Book Value Data

View and export this data back to 1998. Start Trial.
Date Value
October 07, 2026 3.934
October 06, 2026 3.894
October 05, 2026 3.850
October 02, 2026 3.862
October 01, 2026 3.754
September 30, 2026 3.968
September 29, 2026 3.934
September 28, 2026 4.031
September 25, 2026 4.276
September 24, 2026 3.935
September 23, 2026 3.972
September 22, 2026 4.318
September 21, 2026 4.193
September 18, 2026 4.276
September 17, 2026 4.276
September 16, 2026 4.442
September 15, 2026 4.401
September 14, 2026 4.442
September 11, 2026 4.193
September 10, 2026 4.235
September 09, 2026 4.276
September 08, 2026 4.526
September 04, 2026 4.484
September 03, 2026 4.567
September 02, 2026 4.608
Date Value
September 01, 2026 4.484
August 31, 2026 4.567
August 28, 2026 4.608
August 27, 2026 4.816
August 26, 2026 4.65
August 25, 2026 4.692
August 24, 2026 4.526
August 21, 2026 4.484
August 20, 2026 4.484
August 19, 2026 4.567
August 18, 2026 4.401
August 17, 2026 4.401
August 14, 2026 4.442
August 13, 2026 4.401
August 12, 2026 4.567
August 11, 2026 4.65
August 10, 2026 4.692
August 07, 2026 4.567
August 06, 2026 4.692
August 05, 2026 4.733
August 04, 2026 4.65
August 03, 2026 4.608
July 31, 2026 4.484
July 30, 2026 4.608
July 29, 2026 4.401

Price to Book Ratio Definition

Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.

Read full definition.

Price to Book Value Range, Past 5 Years

View Price to Book Value Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value Benchmarks

View Price to Book Value Benchmarks
Start Trial
Agenus, Inc. --
Amgen, Inc. 18.84
BioCryst Pharmaceuticals, Inc. --
Imunon, Inc. 1.181
Curis, Inc. 0.3001

Price to Book Value Related Metrics

PS Ratio 19.48
PEG Ratio -5.974
Price 1.025
Earnings Yield -17.98%
Market Cap 259.23M
PEGY Ratio -5.974